Tuberculin Market Overview

An overview of conceptual frameworks, analytical approaches of the Tuberculin market is the main objective of the report, which further consists the market opportunity and insights of the data involved in the making of the respective market. Tuberculin market is expected to grow with significant rate in the near future.

The global Tuberculin Market in 2020 is estimated for more than US$ 231.9 Mn and expected to reach a value of US$ 359.2 Mn by 2028 with a significant CAGR of 5.6%.

Tuberculin Market Definition

Tuberculin is a combination of proteins used in the diagnosis of tuberculosis. Tuberculin is used to perform a tuberculin skin test and is recommended only for high-risk tuberculosis patients. Tuberculin was discovered in 1980 and originally it was developed as a remedy for tuberculosis but was found to be ineffective.

Tuberculin test is referred to as a Mantoux test. Patients with active tuberculosis are indicated as tuberculin positive and upon intradermals injection of tuberculin develop hypersensitivity reaction at the site of injection. Tuberculin is obtained from a human strain of Mycobacterium tuberculosis grown on a protein-free synthetic medium and buffered with potassium and sodium phosphates.

Tuberculin Market Dynamics

Growing incidence of infectious diseases including tuberculosis is the first and foremost factor driving the growth of tuberculin market. According to the Center for Disease Control and Prevention (CDC), one-third of the global population is infected with tuberculosis and there were 1.7 Bn tuberculosis-related deaths globally in 2017.

In U.S. 9,272 new cases of tuberculosis were reported in 2017. Commonly used brands of tuberculin include Aplisol and Tubersol. In the recent past, there has been a shortage of tuberculin due to the economic slowdown in several countries in Europe. However, the tuberculin market is gaining traction over the forecast period after the restoration of the economy.

Tuberculin Market Key Players

Global tuberculin market is mainly dominated by:

Sanofi SA

Zoetis

Par Pharmaceuticals

Japan BCG

Sanroad Biological

CNBG

Tuberculin Market Segmentation

The global tuberculin market is segmented on the basis of product type, end-user, and region. On the basis of product type, the global tuberculin market is segmented into:

Purified Protein Derivative S (PPD S)

Purified Protein Derivative RT23 (PPD RT23)

Others

By end-user, global tuberculin market is segmented into:

Hospitals

Diagnostic Centers

Others (e.g. government programs, etc)

On the basis of region, the global tuberculin market is segmented into six regions namely:

North America

Latin America

Asia Pacific

Europe

Middle East

Africa

Tuberculin Market Regional Segmentation Overview

North America tuberculin market is expected to be the most dominating market throughout the forecast period due to the growing number of tuberculosis cases each year. Despite the economic slowdown, Europe will maintain its second largest position with Germany and U.K being the most attractive markets within the region.

MMC Overview on Tuberculin Market Report

The non-identical approach of Meridian Market Consultants stands with conceptual methods backed up with the data analysis. The novel market understanding approach makes up the standard of the assessment results that give better opportunity for the customers to put their effort.

A research report on the Tuberculin market by Meridian Market Consultants is an in-depth and extensive study of the market based on the necessary data crunching and statistical analysis. It provides a brief view of the dynamics flowing through the market, which includes the factors that supports market and the factors that are acting as impedance for the growth of the market.

Furthermore, the report includes the various trends and opportunities in the respective market in different regions for a better understanding of readers that helps to analyze the potential of the market. The report is titled as ‘Tuberculin Market: Opportunity Analysis and Future Assessment 2020-2028’.

Factors that are benchmarked while estimating the market

Various factors that are benchmarked while estimating the market growth include (but not restricted to):

•    New product designs and launches

•    Current product compliance

•    Reimbursement

•    Concerns for use of Tuberculin

•    Advantage of Tuberculin

Actions taken by the manufacturer and respective regulatory authorities also impact the market growth of the segment. These factors are understood at regional level and in major countries globally for providing regional insights of the product segment in the report. This helps our clients to take informed decision.

A mix of top-down and bottom-up approach is followed to arrive and validate our market value estimations. For a product segment like wherein one/two manufacturer(s) dominates the market, it’s products sales, previous growth rates and market expansion plans are considered to generate market share in the global market.

1.    Global Tuberculin Market Report Overview

1.1.    Introduction

1.2.    Report Description

1.3.    Methodology

2.    Global Tuberculin Market Overview

2.1.    Introduction

2.1.1.    Market Definition

2.1.2.    Market Taxonomy

2.2.    Executive Summary

2.3.    Global Tuberculin Market Snapshot

2.4.    Global Tuberculin Market Size and Forecast, 2020–2028

2.4.1.    Introduction

2.4.2.    Market Value Forecast and Annual Growth Rate (AGR) Comparison (2020–2028)

2.5.    Global Tuberculin Market Dynamics

2.5.1.    Drivers

2.5.2.    Restraints

2.5.3.    Opportunity

2.5.4.    Trends

2.6.    Key Regulations

2.7.    Porter’s Five Forces Model

3.    Global Tuberculin Market, By Product Type

3.1.    Introduction

3.1.1.    Annual Growth Rate Comparison, By Product Type

3.1.2.    BPS Analysis, By Product Type

3.2.    Market Revenue (US$Mn) Forecast, By Product Type

3.2.1.    Purified Protein Derivative S (PPD S)

3.2.2.    Purified Protein Derivative RT23 (PPD RT23)

3.2.3.    Others

3.3.    Global Tuberculin Market Attractiveness Index, By Product Type

4.    Global Tuberculin Market, By End User

4.1.    Introduction

4.1.1.    Annual Growth Rate Comparison, By End User

4.1.2.    BPS Analysis, By End User

4.2.    Market Revenue (US$Mn) Forecast, By End User

4.2.1.    Hospitals

4.2.2.    Diagnostic Centers

4.2.3.    Others

4.3.    Global Tuberculin Market Attractiveness Index, By End User

5.    Global Tuberculin Market, By Region

5.1.    Introduction

5.1.1.    Annual Growth Rate Comparison, By Region

5.1.2.    BPS Analysis, By Region

5.2.    Market Revenue (US$Mn) Forecast, By Region

5.2.1.    North America

5.2.2.    Latin America

5.2.3.    Europe

5.2.4.    Asia Pacific

5.2.5.    Middle East and Africa

5.3.    Global Tuberculin Market Attractiveness Index, By Region

6.    North America Tuberculin Market Analysis and Forecast, 2020–2028

6.1.    Introduction

6.1.1.    Annual Growth Rate Comparison, By Country

6.1.2.    BPS Analysis, By Country

6.2.    Market Revenue (US$Mn) Forecast, By Country

6.2.1.    U.S. Tuberculin Market

6.2.2.    Canada Tuberculin Market

6.3.    North America Tuberculin Market, By Product Type

6.3.1.    Purified Protein Derivative S (PPD S)

6.3.2.    Purified Protein Derivative RT23 (PPD RT23)

6.3.3.    Others

6.4.    North America Tuberculin Market, By End User

6.4.1.    Hospitals

6.4.2.    Diagnostic Centers

6.4.3.    Others

6.5.    North America Tuberculin Market Attractiveness Index

6.5.1.    By Country

6.5.2.    By Product Type

6.5.3.    By End User

7.    Latin America Tuberculin Market Analysis and Forecast, 2020–2028

7.1.    Introduction

7.1.1.    Annual Growth Rate Comparison, By Country

7.1.2.    BPS Analysis, By Country

7.2.    Market (US$Mn) Forecast, By Country

7.2.1.    Brazil Tuberculin Market

7.2.2.    Mexico Tuberculin Market

7.2.3.    Argentina Tuberculin Market

7.2.4.    Rest of Latin America Tuberculin Market

7.3.    Latin America Tuberculin Market, By Product Type

7.3.1.    Purified Protein Derivative S (PPD S)

7.3.2.    Purified Protein Derivative RT23 (PPD RT23)

7.3.3.    Others

7.4.    Latin America Tuberculin Market, By End User

7.4.1.    Hospitals

7.4.2.    Diagnostic Centers

7.4.3.    Others

7.5.    Latin America Tuberculin Market Attractiveness Index

7.5.1.    By Country

7.5.2.    By Product Type

7.5.3.    By End User

8.    Europe Tuberculin Market Analysis and Forecast, 2020–2028

8.1.    Introduction

8.1.1.    Annual Growth Rate Comparison, By Country

8.1.2.    BPS Analysis, By Country

8.2.    Market (US$Mn) Forecast, By Country

8.2.1.    U.K. Tuberculin Market

8.2.2.    Germany Tuberculin Market

8.2.3.    Italy Tuberculin Market

8.2.4.    France Tuberculin Market

8.2.5.    Spain Tuberculin Market

8.2.6.    Russia Tuberculin Market

8.2.7.    Poland Tuberculin Market

8.2.8.    BENELUX Tuberculin Market

8.2.9.    NORDIC Tuberculin Market

8.2.10.    Rest of Europe Tuberculin Market

8.3.    Europe Tuberculin Market, By Product Type

8.3.1.    Purified Protein Derivative S (PPD S)

8.3.2.    Purified Protein Derivative RT23 (PPD RT23)

8.3.3.    Others

8.4.    Europe Tuberculin Market, By End User

8.4.1.    Hospitals

8.4.2.    Diagnostic Centers

8.4.3.    Others

8.5.    Europe Tuberculin Market Attractiveness Index

8.5.1.    By Country

8.5.2.    By Product Type

8.5.3.    By End User

9.    Asia Pacific Tuberculin Market Analysis and Forecast, 2020–2028

9.1.    Introduction

9.1.1.    Annual Growth Rate Comparison, By Country

9.1.2.    BPS Analysis, By Country

9.2.    Market (US$Mn) Forecast, By Country

9.2.1.    China Tuberculin Market

9.2.2.    India Tuberculin Market

9.2.3.    Japan Tuberculin Market

9.2.4.    Australia and New Zealand Tuberculin Market

9.2.5.    South Korea Tuberculin Market

9.2.6.    ASEAN Tuberculin Market

9.2.7.    Rest of Asia Pacific Tuberculin Market

9.3.    Asia Pacific Tuberculin Market, By Product Type

9.3.1.    Purified Protein Derivative S (PPD S)

9.3.2.    Purified Protein Derivative RT23 (PPD RT23)

9.3.3.    Others

9.4.    Asia Pacific Tuberculin Market, By End User

9.4.1.    Hospitals

9.4.2.    Diagnostic Centers

9.4.3.    Others

9.5.    Asia Pacific Tuberculin Market Attractiveness Index

9.5.1.    By Country

9.5.2.    By Product Type

9.5.3.    By End User

10.    Middle East Tuberculin Market, By Region

10.1.    Introduction

10.1.1.    Annual Growth Rate Comparison, By Country

10.1.2.    BPS Analysis, By Country

10.2.    Market (US$Mn) Forecast, By Country

10.2.1.    GCC Countries Tuberculin Market

10.2.2.    Israel Tuberculin Market

10.2.3.    Oman Tuberculin Market

10.2.4.    Rest of Middle East Tuberculin Market

10.3.    Middle East Tuberculin Market, By Product Type

10.3.1.    Purified Protein Derivative S (PPD S)

10.3.2.    Purified Protein Derivative RT23 (PPD RT23)

10.3.3.    Others

10.4.    Middle East Tuberculin Market, By End User

10.4.1.    Hospitals

10.4.2.    Diagnostic Centers

10.4.3.    Others

10.5.    Middle East Tuberculin Market Attractiveness Index

10.5.1.    By Country

10.5.2.    By Product Type

10.5.3.    By End User

11.    Africa Tuberculin Market, By Region

11.1.    Introduction

11.1.1.    Annual Growth Rate Comparison, By Country

11.1.2.    BPS Analysis, By Country

11.2.    Market (US$Mn) Forecast, By Country

11.2.1.    South Africa Tuberculin Market

11.2.2.    Egypt Tuberculin Market

11.2.3.    North Africa Tuberculin Market

11.2.4.    Rest of Africa Tuberculin Market

11.3.    Africa Tuberculin Market, By Product Type

11.3.1.    Purified Protein Derivative S (PPD S)

11.3.2.    Purified Protein Derivative RT23 (PPD RT23)

11.3.3.    Others

11.4.    Africa Tuberculin Market, By End User

11.4.1.    Hospitals

11.4.2.    Diagnostic Centers

11.4.3.    Others

11.5.    Africa Tuberculin Market Attractiveness Index

11.5.1.    By Country

11.5.2.    By Product Type

11.5.3.    By End User

12.    Recommendation

12.1.    Market Strategy

13.    Competitive Landscape

13.1.    Competition Dashboard

13.2.    List and Company Overview of Global Key Players

13.3.    Company Profiles

13.3.1.    Sanofi Pasteur

13.3.1.1.    Company Overview

13.3.1.2.    Financial Overview

13.3.1.3.    Product Portfolio

13.3.1.4.    Key Developments

13.3.1.5.    Business Strategies

13.3.2.    Zoetis 

13.3.3.    Par Sterile 

13.3.4.    SSI 

13.3.5.    Japan BCG 

13.3.6.    Thermo Fisher 

13.3.7.    Sanroad Biological 

13.3.8.    CNBG

13.3.9.    Par Pharmaceuticals

13.3.10.  Sanroad Biological and CNBG

14.    Acronyms